As a healthcare provider, I want to add some clinical context to this discussion on Semaglutide cardiovascular benefit.
Building on what lori_vegas said — the evidence base here is well-established. The key publications to reference are from the SUSTAIN program[1].
Key clinical points:
- Efficacy is dose-dependent and typically requires 4-5 weeks to reach steady state
- Side effect profile is predictable and usually manageable with standard protocols
- Monitoring should include baseline labs and follow-up at 3-month intervals
- Patient education significantly improves outcomes and adherence
Standard disclaimer: this is educational, not individualized medical advice.
[1] See thread title for relevant study identification.
mike_mod said:The first 6 weeks are the hardest
Gonna push back on this one. Semaglutide cardiovascular benefit is not that straightforward in my experience. I have been on this for 18 months and the reality is messier than the trials suggest.
Don't get me wrong — the medication works. But adherence is harder than people admit. We should be honest about that.
Subscribing to this thread. Semaglutide is exactly what I've been researching. 🙏
Reading this thread on Semaglutide hits close to home. Dad of 2 checking in — I started at 265 lbs and felt like I would tried everything.
11 months on tirz and I am a different person. Not just the 40 lbs lost — my energy, my mood, my relationship with food. All transformed.
If you are on the fence about Semaglutide — take the leap. It was the best health decision I have ever made. ❤️